Swedish prostate cancer patients are seeking radiation therapy at the Universitetssjukhuset i Monza in Italy, utilizing high-precision technology developed by Swedish firm Micropos Medical to minimize common side effects. Traditional radiation and surgical treatments carry risks of complications including inkontinens, täta trängningar, tarmläckage, and erectile dysfunction, often because the prostate gland can shift by more than 10 millimeters during treatment. By contrast, the clinic in Monza delivers precisely targeted radiation over just four sessions in a single week.
High-Precision Tracking Technology
The accuracy required for condensed radiation schedules is achieved through the Raypilot System, a real-time 3D monitoring technology designed by Gothenburg-based Micropos Medical. Operating since 2020 across clinics in several European countries, the system monitors prostate movement continuously and alerts the clinical team if the gland shifts beyond a tolerance threshold, typically set at two millimeters. Thomas Lindström of Micropos Medical states that millimetric precision allows for effective treatment with lower risk for biverkningar while streamlining clinical workflows from two to seven weeks down to a few days.
While radiation therapy in Sweden typically spans anywhere from seven to 39 sessions, Swedish patients treated in Monza completed their protocols in four sessions. The Italian facility is also conducting a study evaluating radiation at only one occasion with favorable initial outcomes. Despite the technology originating in Sweden, the Raypilot System is not used in Sweden.
Patient Experiences and Legal Challenges
Martin Lundberg, a 59-year-old patient from Halland, discovered an aggressive form of prostate cancer after pushing for a PSA test despite initial medical resistance. Having previously encountered the Raypilot System through professional work, Lundberg chose to bypass surgical recommendations and financed his own care in Monza after confirming the cancer had not spread. He completed four days of treatment in early December without experiencing complications.
Following a favorable follow-up PSA test four months post-treatment, Lundberg has actively campaigned for improved national guidelines for prostate cancer care and wider availability of the method. He has been denied reimbursement for his medical expenses from Försäkringskassan and is pursuing the matter legally. Clas Ericsson, a 68-year-old patient from Stockholm whose cancer was detected through a regional PSA screening program, faced a similar decision-making process after being advised that surgery was necessary.
Comparative Treatment Overview
| Treatment Parameter | Standard Swedish Care | Monza Clinic Protocol (Italy) |
|---|---|---|
| Treatment Duration | 7 to 39 sessions | 4 sessions (1 week) |
| Tumor Tracking | Not specified | Real-time 3D monitoring (Raypilot System) |
| Tolerance Threshold | Not specified | 2 millimeters |
Worth a look